Skip to main content
. 2016 Jan 13;8:199–204. doi: 10.1016/j.redox.2015.11.007

Fig. 6.

Fig. 6

Serum Levels of NO. Controls were abbreviated as (C), untreated diabetic group as (HFD+STZ), diabetic group treated with melatonin 10 mg/kg/day as (HFD+STZ+MLT), diabetic group treated with L-carnitine 0.6 g/kg/day as (HFD+STZ+LC) and diabetic group treated with glibenclamide 5 mg/kg/day was abbreviated as (HFD+STZ+GB). The results are shown as Values±SEM n=7 in all the groups. *p<0.05 shows the statistical significance compared to the controls, #p<0.05 shows the statistical significance compared to the untreated diabetic group.